- CEO
- Xin Xiang Zhai
- Full Time Employees
- 2,796
- Sector
- Utilities
- Industry
- Water utilities
- Address
- China Merchants Tower Hong Kong Hong Kong
- IPO Date
- Dec 10, 1997
- Business
- Tianjin Development Holdings Limited is an investment holding company principally engaged in utilities supply and diversified operations including pharmaceuticals, hotels, electrical and mechanical engineering, port services, and elevators and escalators in the People's Republic of China. The company operates through six main segments: the Utilities segment distributes electricity with an installed transmission capacity of approximately 996,000 kVA, water with a daily supply capacity of 325,000 tonnes, heat, and thermal power via approximately 549 kilometres of steam transmission pipelines, 120 processing stations, and a daily steam distribution capacity of approximately 30,000 tonnes to industrial, commercial, and residential customers; the Pharmaceutical segment, including Lisheng Pharmaceutical (002393.SZ) and Yiyao Printing, manufactures and sells pharmaceutical products, provides research and development services, and offers design, manufacture, and printing for pharmaceutical packaging as well as other paper-based packaging materials; the Hotels segment manages properties such as Courtyard by Marriott Hong Kong; the Electrical and Mechanical segment manufactures and sells presses, mechanical and hydroelectric equipment, and large-scale pump units; the Port Services segment provides container and cargo handling services through its listed associate Tianjin Port Development Holdings Limited (3382.HK), in which it holds a 21% stake accounted for using the equity method; and the Elevators and Escalators segment manufactures and sells elevators and escalators via its 16.55% stake in Otis Elevator (China) Investment Company Limited, also accounted for using the equity method. Incorporated on May 9, 1997 and headquartered at Suites 7-13, 36th Floor, China Merchants Tower, 168-200 Connaught Road Central, Hong Kong, the company primarily serves markets in China and is a subsidiary of Tsinlien Group Company Limited, with a workforce of approximately 2,740 employees. Recent developments include the renewal of key connected transaction agreements with Tianjin TEDA Investment Holding Co. Ltd. in November 2024 for water testing services, steam purchases, and other utilities-related arrangements effective from January 2025 for three years, pending shareholder approval at an extraordinary general meeting; a unit's entry into a partnership in September 2025 to establish a RMB500 million fund; and the acquisition of Jiangxi Qingchun Kangyuan Pharmaceutical Co., Ltd. and its subsidiary during the first half of 2025, alongside property, plant, and equipment additions of HK$25.93 million in the interim period ended June 30, 2025 to support business expansion.